Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Vasodilators may worsen abdominal aortic aneurysm.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.